Category: Replacement Heart Valves
Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its outlook for the rest of the year.
Medtronic reports positive data from a study evaluating an alternative implantation procedure for its CoreValve aortic valve-replacement device.
An FDA advisory panel recommends that CryoLife's heart valve, the CryoValve allograft, be subject to its most-stringent pre-market approval protocol.
Sorin announces the first U.S. implant of its recently approved Solo Smart aortic heart valve.
Sorin Group (BIT:SRN) said that a patient in Indianapolis was the first U.S. recipient of its recently approved Solo Smart aortic heart valve.
Claret Medical launches a pivotal U.S. trial for its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.
Claret Medical said today that the 1st patient has been treated in a U.S. pivotal trial of its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.
Edwards Lifesciences is flirting with all time highs on The Street after nearly 2 years of bearish results.
Edwards Lifesciences (NYSE:EW) is back in Wall Street's good graces, with shares of the Irvine, Calif.-based heart valve maker approaching all time highs after nearly 2 years of down performance.
Direct Flow Medical chalks up CE Mark approval in the European Union for an enhanced delivery system for its transcatheter aortic valve implant.